Gairdner Science Week 2026
Nodes

October 22:2026 Gairdner International Symposium: After the Gairdner Award—Where Next?

Share this event

This symposium brings together 2026 Gairdner Laureates and leading researchers to explore how breakthrough discoveries evolve into transformative therapies and shape the future of medicine.

Featured Speakers Include:

  • Jeffery Kelly, 2026 Canada Gairdner International Award laureate
  • Matthias Mann, 2026 Canada Gairdner International Award laureate
  • Aaron Phillips, 2026 Peter Gilgan Canada Gairdner Momentum Award laureate
  • Megan Levings, Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia and BC Children’s Hospital Research Institute
  • Felicia Pagliuca, Senior Vice President, Cell and Genetic Therapy Research at Vertex Pharmaceuticals

 

Register here

Unable to attend in person? Join us via livestream: https://bit.ly/GSW-2026-Livestream

Schedule

9:00 AM 

Chair Remarks 

9:05 AM 

Tafamidis Led to 10 Drugs for Treating Amyloid Diseases: What Remains to Do? 

 Dr. Jeffery W. Kelly, H. Lutcher Brown Professor of Chemistry, Department of Chemistry, Scripps Research, La Jolla, United States

9:35 AM 

Moderated Q/A 

9:45 AM 

Leveraging heart-brain connections for novel treatments 

 Dr. Aaron Phillips, Associate Professor, Departments of Clinical Neurosciences, Cardiac Sciences, Physiology and Pharmacology, University of Calgary; Associate Dean, Innovation and Commercialization, Cumming School of Medicine, University of Calgary, Canada

10:15 AM 

Moderated Q/A 

10:25 AM 

Regulating Human Immunity 

 Dr. Megan Levings, PhD, Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia; Scientist, BC Children's Hospital Research Institute

10:55 AM 

Moderated Q/A 

11:00 AM 

Bio Break 

11:25 AM 

Stem Cell Derived Islets for Type 1 Diabetes 

 Dr. Felicia Pagliuca, PhD, Senior Vice President, Cell and Genetic Therapy Research & Site Head, Vertex Pharmaceuticals, San Diego, CA, USA

11:55 PM 

Moderated Q/A 

12:05 PM 

Mass spectrometry-based proteomics: from precision instrumentation to saving patients' lives 

 Dr. Matthias Mann, Director of Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
12:35 PM Moderated Q/A 

12:40 PM 

Chair Closing Remarks 

Location

MaRS Auditorium, Concourse Level, 101 College Street, Toronto